WFIKKN1 and WFIKKN2 are two closely related multidomain proteins consisting of a WAP (whey acidic protein)-, a follistatin-, an immunoglobulin-, two Kunitz-type protease inhibitor-domains and an NTR domain (netrin domain). Recent experiments have shown that both WFIKKN1 and WFIKKN2 bind myostatin and GDF11 (growth and differentiation factor 11) with high affinity and are potent antagonists of these growth factors. Structure-function studies on WFIKKN proteins have revealed that their interactions with GDF8 and GDF11 are mediated primarily by the follistatin and NTR domains.
Structure and evolution of WFIKKN proteins
Using sensitive homology-search and gene-finding programmes, we have identified two closely related human genes, WFIKKN1 and WFIKKN2 (originally designated as WFIKKN and WFIKKNRP) on chromosomes 16 and 17 respectively [1, 2] . WFIKKN1 and WFIKKN2 are secreted multidomain proteins with identical domain architecture: both consist of a WAP (whey acidic protein)-, a follistatin-, an immunoglobulin-, two Kunitz-type protease inhibitor-and an NTR domain (netrin domain) ( Figure 1 ). The exon-intron structure of the two genes is also identical: both genes have a single phase-0 intron that splits their WAP domains in an equivalent position.
Searches of public databases have identified full-length orthologues of WFIKKN proteins from urochordates (Ciona intestinalis), all groups of vertebrates (lamprey, bony fishes, frog, chicken and mammals), but not from non-chordate animals, suggesting that the common ancestor of WFIKKN proteins was formed in the chordate lineage [3] .
The WFIKKN protein of C. intestinalis, however, differs from vertebrate proteins in that it lacks an immunoglobulin domain. Phylogenetic analyses of domains shared by WFIKKN-related proteins of urochordates and vertebrates have revealed that the Ciona protein is basal to WFIKKN1 and WFIKKN2 branches, indicating that the gene duplication of the ancestral WFIKKN gene occurred in vertebrata after their divergence from urochordata, their closest invertebrate relatives [3] .
The genomes of chicken and mammals were found to contain single WFIKKN1 and WFIKKN2 genes, but in the case of completely sequenced fish genomes (Fugu rubripes, Tetraodon nigroviridens and Danio rerio), there was evidence for a single WFIKKN1-and two WFIKKN2-related genes [3] .
Expression of WFIKKN proteins
Studies on the tissue-expression pattern of the two human WFIKKN genes have revealed pronounced differences. Whereas the WFIKKN1 gene is expressed primarily in pancreas, liver, thymus, kidney and lung, significant expression of the WFIKKN2 gene is observed in ovary, testis and brain. In human fetal tissues, the expression of WFIKKN1 was highest in lung, skeletal muscle and liver, whereas WFIKKN2 expression was found in brain, skeletal muscle, kidney and thymus [2] . It was shown that OC29 (the rat orthologue of human WFIKKN1) is also expressed in the presumptive cristae of the developing inner ear [4] .
Molecular interactions of WFIKKN proteins
WFIKKN1 and WFIKKN2 proteins inhibit the activity of trypsin WFIKKN proteins contain several domain types that have been implicated in inhibition of various types of proteases: the WAP-and Kunitz-type protease inhibitor modules frequently function as serine protease inhibitors [5] , the NTR domain is responsible for the inhibitory activity of TIMPs (tissue inhibitor of metalloproteinases) [6] . On the basis of their domain composition, we have hypothesized that WFIKKNs might function as multivalent protease inhibitors that may control the action of several proteases.
To test this hypothesis, we have produced the recombinant full-length WFIKKN1 and WFIKKN2 proteins, some of their domains and domain combinations and studied their effect on the proteolytic activity of various proteases. Fulllength WFIKKN proteins inhibited the proteolytic activity of bovine trypsin but had no effect on the peptidolytic activity of bovine elastase, chymotrypsin, tissue-type plasminogen activator, urokinase-type plasminogen activator, furin and 
The trypsin inhibitory activity of WFIKKN1 and WFIKKN2 is meditated by the second Kunitz-type domain
At the domain level, the trypsin inhibitory activity of WFIKKN proteins was assigned to the second Kunitz-type domain; the fragment containing the WAP and follistatin domains of WFIKKN2 (WFIKKN2_WAP-FS) did not inhibit the activity of trypsin, chymotrypsin or elastase [7] .
The second Kunitz-type domain of WFIKKN1 (WFIKKN1_KU2) showed remarkable specificity for trypsin since it did not inhibit the activity of elastase, chymotrypsin or various proteases with trypsinlike specificity (plasmin, pancreatic kallikrein, lung tryptase, plasma kallikrein, thrombin, urokinase or tissue plasminogen activator) [7] . Despite this trypsin-specificity, WFIKKN1_KU2 domain is a poor inhibitor of trypsin: the inhibition constant of the WFIKKN1_KU2 protein for bovine trypsin (K i = 9.6 nM) is approximately five orders of magnitude higher than that of BPTI (bovine pancreatic trypsin inhibitor) for trypsin [7] . NMR studies on the solution structure of this domain and evolutionary analyses raised the possibility that trypsin may not be the prime target of this Kunitz domain [8] .
WFIKKN proteins bind several members of the TGFβ (transforming growth factor β) family
Using an affinity purification-based approach, Hill et al. [9] have identified the mouse orthologues of human WFIKKN2 {which they named as GASP1 [GDF (growth and differentiation factor)-associated serum protein-1]} as a myostatin-binding protein and implicated it in the regulation of muscle development. Myostatin, a member of the TGFβ family, acts primarily as a negative regulator of muscle growth; deletion of myostatin gene or mutations in the myostatin gene cause the increase of skeletal muscle mass as a result of a combination of muscle fibre hypertrophy and hyperplasia [10, 11] . Since their affinity purificationbased approach failed to identify WFIKKN1 as a myostatinbinding protein, Hill et al. [9] suggested that WFIKKN1 probably has a different biological specificity or that it is not present in serum.
To test the former possibility, we have immobilized recombinant mouse myostatin on the surface of sensor chip CM5 and performed SPR (surface plasmon resonance) measurements with both human WFIKKN1 and human WFIKKN2. Our studies have revealed that WFIKKN1 protein also has high affinity for immobilized myostatin [3] M respectively. Myostatin is closely related to GDF11 (also known as BMP11) but despite their high degree of sequence similarity the biological functions of myostatin and GDF11 are markedly different. GDF11 plays a crucial role in anteriorposterior patterning of the axial skeleton; GDF11 knockout mouse displays skeletal defects resulting from abnormal anterior-posterior patterning [12] [13] [14] . To investigate whether WFIKKN1 and WFIKKN2 bind GDF11 with similar or different affinities, we have immobilized recombinant human GDF11 on sensor chip CM5 and performed SPR measurements with human WFIKKN1 and human WFIKKN2. Both WFIKKN1 and WFIKKN2 showed high affinity for immobilized GDF11: the K d values for binding of WFIKKN1 and WFIKKN2 to GDF11 were calculated to be 2.25×10 − 9 and 1.64×10 − 10 M respectively [3] . SPR interaction experiments with several additional representatives of the TGFβ family revealed that, in addition to myostatin and GDF11, both WFIKKN proteins bind TGFβ1, BMP2 and BMP4 with relatively high affinity (K d ∼10 − 7 -10 − 8 M), weak interaction was detected with BMP3 and BMP8b and no detectable affinity was found for activin A [15] .
To decide whether WFIKKN proteins may block the binding of various growth factors to their cognate receptors, we have studied their influence on the binding of growth factors to growth factors' receptors in SPR assays (using solution-competition assay formats) as well as in reporter assays [15] . In SPR solution-competition assays, the extracellular ligand-binding domain of the appropriate receptor was immobilized on the sensor chip surface and the growth factor solution pre-incubated with increasing concentrations of WFIKKN1 and WFIKKN2 were injected. In the case of myostatin and GDF11, increasing concentrations of WFIKKN1 or WFIKKN2 efficiently decreased the recorded SPR response and association rate, indicating that the GDF8-WFIKKN1 and GDF8-WFIKKN2 complexes formed are unable to bind to the extracellular domain of the receptor, ACRIIB (activin receptor IIB).
WFIKKN1 and WFIKKN2 were quite efficient antagonists of myostatin and GDF11. In the case of myostatin, WFIKKN1 and WFIKKN2 caused 50% decrease in the rate of association of the growth factor with ACRIIB at ∼20 and ∼12 nM respectively, whereas in the case of GDF11 these values were ∼40 and ∼5 nM respectively.
In harmony with these observations both WFIKKN1 and WFIKKN2 efficiently inhibited the activity of myostatin and GDF11 in reporter assays, half-maximal inhibition being achieved by ∼6 nM WFIKKN1 and by ∼3 nM WFIKKN2 in the case of myostatin. Similarly, WFIKKN1 and WFIKKN2 inhibited the activity of GDF11; 50 nM WFIKKN1 and WFIKKN2 caused 80 and 90% inhibition respectively [15] . These experiments suggest that both WFIKKN1 and WFIKKN2 are potent inhibitors of myostatin and GDF11 and may play a significant role in the regulation of biological processes controlled by these growth factors.
In the case of BMP2, BMP4 and TGFβ1, solutioncompetition assays revealed that WFIKKN proteins inhibit the binding of these growth factors to immobilized extracellular domains of their receptors at concentrations in the micromolar range, but, in reporter assays, neither WFIKKN1 nor WFIKKN2 inhibited the activity of BMP2, BMP4 and TGFβ1 [15] .
WFIKKN1 binds GDF8 primarily through its follistatin domain
It has been shown previously that myostatin binds to follistatin and the follistatin-related protein, FLRG (follistatin-related gene), with high affinity [16, 17] ; therefore we have assumed that the follistatin domains are likely candidates for these interactions. To identify the regions of WFIKKN1 that contribute to its interaction with myostatin, we have characterized the interactions of myostatin with recombinant proteins containing its follistatin domain (WFIKKN1_FS), its NTR domain (WFIKKN1_NTR), as well as proteins containing the WAP and follistatin domain (WFIKKN1_WAP-FS), the two Kunitz domains (WFIKKN1_KU1-KU2) or the second Kunitz and NTR domains (WFIKKN1_KU2-NTR). SPR analysis of the binding of WFIKKN1 and various WFIKKN1 fragments to immobilized myostatin revealed that their affinity decreased in the order WFIKKN1>WFIKKN1_WAP-FS>WFIKKN1_FS>WFIKKN1_KU2-NTR∼WFIKKN1 _NTR with no interaction being detectable in the case of WFIKKN1_KU1-KU2 protein [3] . Based on these analyses, it appears that WFIKKN proteins bind mature growth factors primarily through interactions with the follistatin domain, but their NTR domains also contribute to the interaction.
WFIKKN1 binds myostatin propeptide through the NTR domain
Myostatin and GDF11, similar to other members of the TGFβ superfamily, are produced from precursor proteins by proteolytic processing (Figure 2) . After cleavage of a single peptide bond by a furin-type protease, the N-terminal propeptide and the disulfide-bonded homodimer containing the mature growth factor domains remain associated, forming an inactive complex known as the latent complex [16] [17] [18] . The active mature growth factors may be liberated from the latent complexes through degradation of the propeptide by a variety of proteases. Members of the BMP1/tolloid family of metalloproteinases are known to play key roles in the cleavage of the propeptides of both myostatin and GDF11 [19, 20] .
Since WFIKKN2 protein was shown to bind not only mature myostatin but also the propeptide region of myostatin [9] , we investigated the interaction of WFIKKN1 and myostatin propeptide by SPR measurements. Our experiments confirmed that the propeptide region of myostatin binds to WFIKKN1 independently from mature myostatin with a K d value of 4.85×10 − 7 M [3] . The panel of recombinant proteins containing different fragments of WFIKKN1 protein was used to identify the region(s) that participate in the interaction of WFIKKN1 with the propeptide region of myostatin. These studies revealed that the propeptide region of myostatin binds only to WFIKKN1_KU2-NTR and WFIKKN1_NTR, suggesting that the NTR domain of WFIKKN1 mediates the interaction [3] .
Conclusions and future directions
WFIKKN1 and WFIKKN2 are two closely related multidomain proteins that have identical domain architectures and participate in similar molecular interactions in as much as both inhibit the activity of trypsin, bind a similar spectrum of growth factors of the TGFβ family and bind the propeptide domain of myostatin.
Much less is known about the biological functions of the various interactions. However, since both WFIKKN1 and WFIKKN2 are potent antagonists of myostatin and GDF11, it seems safe to assume that these proteins play a crucial role in the control of processes regulated by these growth factors. In view of the fact that the pattern of affinities of WFIKKN1 and WFIKKN2 for growth factors are similar, but their pattern of expression is different, it is likely that it is the expression pattern of WFIKKN1 and WFIKKN2 that determines which of them may be responsible for the control of the activity of GDF8 or GDF11 in a given tissue. The assumption that the primary function of WFIKKNs is to antagonize the activity of myostatin and GDF11 triggers several questions that remain to be explored ( Figure 2 ).
(i) What is the function of the interaction of the propeptide region with WFIKKNs in the regulation of the activity of myostatin and GDF11? One possibility is that the interaction of WFIKKNs with the propeptide domains of the precursors and/or latent complexes may interfere with the release of mature growth factors.
(ii) Does the protease inhibitory activity of WFIKKN proteins play a role in the regulation of the activity of myostatin and GDF11? One may speculate that WFIKKN proteins may block the action of some protease(s) involved in the release of mature growth factors from latent complexes.
We wish to point out that the observation that the WFIKKN proteins do not inhibit the signalling activities of BMP2, BMP4 and TGFβ1 does not necessarily mean that these interactions do not have physiological relevance. Growth factor-binding proteins may control the action of growth factors not only by inhibiting their action but also by serving as a reservoir for growth factors, may localize their action in the vicinity of the binding proteins and thus may help to establish growth factor gradients in the extracellular space through physical association. It may be relevant in this respect that WFIKKN1 is expressed in the developing inner ear, mainly in the BMP4-positive presumptive cristae, and it was suggested that WFIKKN1 might be involved in the early development of the inner-ear sensory organ by controlling the action of BMP4 [4] . 
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